Search

Arrowhead Research Corp. (ARWR)

6.75
-0.05 (-0.74%)
Range6.72 - 7.12
52 week5.47 - 27.63
Open6.91
Vol/Avg.4,687,070
Mkt cap357.1M
P/E-
EPS-1.153
Book/share3.522
Short ratio3.90
PEG-
EPS est.-0.23

ARWR additional information

Loading ...
Market Data powered by QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Filings and Fundamentals by Morningstar, Insiders by Vickers (USA) and SEDI(CDN), analyst ratings by Zacks.

ARWR Profile

Exchange
NASDAQ
Sector
Industry
Executives
Mr. R. Bruce Stewart
Founder
Exec. Chairman Director of Aonex Director of Unidym Director of Insert Therapeutics Inc and Director of Calando

Dr. Christopher R. Anzalone Ph.D.
Chief Exec. Officer
Pres Director Chief Exec. Officer of Calando Chief Exec. Officer of Tego Chief Exec. Officer of Nantope Chief Exec. Officer of Leonardo and Chief Exec. Officerablaris Therapeutics

Mr. Kenneth A. Myszkowski CPA
Chief Financial Officer and Principal Accounting Officer

Mr. Edward W. Frykman
Director
Chairman of Audit Committee Member of Nomination Committee Member of Compensation Committee Director of Insert Therapeutics Inc Director of Unidym Director of Aonex and Director of Calando

Dr. Mauro Ferrari Ph.D.
Director
Member of Nomination Committee and Member of Compensation Committee

Employee Count
18

Competitors

Ticker Last trade Change/%change P/E ratio  
ALNY 88.76 -0.16 / -0.18% -
MRNA 0.82 +0.15 / +22.39% -
ALTI 1.33 +0.02 / +1.53% -
APNT 0.00 N/A / N/A -

ARWR earnings
Brought To You By

Date
Actual
Expected
Prev Yr Qtr
8/12/2010
-0.01
-0.05
8/10/2009
-0.06
-0.20
5/15/2009
-0.12
-0.15